Evidence for early, clinically silent medial temporal lobe inflammation after CAR-T cell therapy
Open Access
- 4 July 2026
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 244, 116925
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (CRC1436)
- European Regional Development Fund
This publication has 9 references indexed in Scilit:
- Long-Term Quality of Life, Cognitive Function, and Symptom Burden Among Chimeric Antigen Receptor T-Cell Recipients and Associated Cytokine Release Syndrome and NeurotoxicityJCO Oncology Practice, 2026
- Immunotherapy-related cognitive impairment after CAR T cell therapy in miceCell, 2025
- Long-term outcomes following CAR T cell therapy: what we know so farNature Reviews Clinical Oncology, 2023
- Peripheral inflammation is associated with brain SPECT perfusion changes in schizophreniaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and managementBlood Reviews, 2019
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cellsNature Medicine, 2018
- Interplay of Hippocampus and Prefrontal Cortex in MemoryCurrent Biology, 2013
- Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged AdultsBiological Psychiatry, 2008
- Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with β-amyloid 1–42 in vitroNeuroscience Letters, 2002